Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases

There is currently an unmet need for better biomarkers across the spectrum of renal diseases. In this paper, we revisit the role of beta-2 microglobulin (β(2)M) as a biomarker in patients with chronic kidney disease and end-stage renal disease. Prior to reviewing the numerous clinical studies in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Argyropoulos, Christos P., Chen, Shan Shan, Ng, Yue-Harn, Roumelioti, Maria-Eleni, Shaffi, Kamran, Singh, Pooja P., Tzamaloukas, Antonios H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471312/
https://www.ncbi.nlm.nih.gov/pubmed/28664159
http://dx.doi.org/10.3389/fmed.2017.00073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471312/
https://www.ncbi.nlm.nih.gov/pubmed/28664159
http://dx.doi.org/10.3389/fmed.2017.00073

Ejemplares similares